Cancer Family
Lung Neoplasm
CI-CAN-00000221Explore in graph →
Non-malignant2,726 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000221Explore in graph →
Clinical trials
11,603 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00193388 | Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer | completed | Phase 2 | 100 | SCRI Development Innovations, LLCOTHER | 0 | Jul 28, 2010 | clinicaltrials |
| NCT00193401 | Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer | completed | Phase 2 | 40 | SCRI Development Innovations, LLCOTHER | 0 | Jul 28, 2010 | clinicaltrials |
| NCT00826852 | Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax | completed | Phase 2 | 49 | SanofiINDUSTRY | 1 | Jul 27, 2010 | clinicaltrials |
| NCT00572325 | Concurrent Chemo-radiation Form NSCLC to a Individualized MLD(BRONC CONC MLD) | completed | — | 180 | Maastricht Radiation OncologyOTHER | 1 | Jul 21, 2010 | clinicaltrials |
| NCT00573040 | Radiotherapy for NSCLC to a Individualized MLD(BRONC MLD) | completed | — | 180 | Maastricht Radiation OncologyOTHER | 1 | Jul 21, 2010 | clinicaltrials |
| NCT00453167 | Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer | completed | Phase 2 | 35 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 12, 2010 | clinicaltrials |
| NCT00316225 | Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen | completed | Phase 2 | 31 | Eli Lilly and CompanyINDUSTRY | 3 | Jul 9, 2010 | clinicaltrials |
| NCT00004225 | Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | completed | Phase 1 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Jul 7, 2010 | clinicaltrials |
| NCT00344773 | First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation | completed | Phase 2 | 46 | AstraZenecaINDUSTRY | 1 | Jun 29, 2010 | clinicaltrials |
| NCT00388089 | Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 24 | University of California, DavisOTHER | 1 | Jun 29, 2010 | clinicaltrials |
| NCT00193245 | Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer | completed | Phase 2 | 80 | SCRI Development Innovations, LLCOTHER | 1 | Jun 28, 2010 | clinicaltrials |
| NCT00193323 | Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients | completed | Phase 2 | 346 | SCRI Development Innovations, LLCOTHER | 1 | Jun 28, 2010 | clinicaltrials |
| NCT00193349 | Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 60 | SCRI Development Innovations, LLCOTHER | 0 | Jun 28, 2010 | clinicaltrials |
| NCT00294931 | Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 50 | SCRI Development Innovations, LLCOTHER | 1 | Jun 28, 2010 | clinicaltrials |
| NCT00308529 | Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer | completed | Phase 2 | 55 | SCRI Development Innovations, LLCOTHER | 1 | Jun 22, 2010 | clinicaltrials |
| NCT00003154 | Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 19 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00006017 | Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer | completed | Phase 2 | 42 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00053300 | Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT01141686 | Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers | completed | — | 90 | Taipei Medical University WanFang HospitalOTHER | 0 | Jun 10, 2010 | clinicaltrials |
| NCT01000740 | A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa | completed | Phase 4 | 59 | AstraZenecaINDUSTRY | 1 | May 21, 2010 | clinicaltrials |
| NCT00113516 | A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 84 | PfizerINDUSTRY | 3 | May 18, 2010 | clinicaltrials |
| NCT01124253 | Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC)(Dengshan) | completed | Phase 3 | 250 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | May 17, 2010 | clinicaltrials |
| NCT00956280 | Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung Cancer | completed | — | 100 | AstraZenecaINDUSTRY | 1 | May 13, 2010 | clinicaltrials |
| NCT00318136 | A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE) | completed | Phase 2 | 47 | Genentech, Inc.INDUSTRY | 0 | May 11, 2010 | clinicaltrials |
| NCT00198393 | Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV | completed | Phase 2 | 126 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Apr 30, 2010 | clinicaltrials |
| NCT00185913 | Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers | completed | — | 50 | Stanford UniversityOTHER | 1 | Apr 22, 2010 | clinicaltrials |
| NCT00063388 | Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer | completed | Phase 2 | 66 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 12, 2010 | clinicaltrials |
| NCT00034541 | Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 32 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00097214 | Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 57 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00097227 | Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 165 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00037713 | Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG | completed | Phase 3 | 515 | Eli Lilly and CompanyINDUSTRY | 0 | Apr 8, 2010 | clinicaltrials |
| NCT00387322 | Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors | completed | Phase 1 / Phase 2 | 42 | University of California, DavisOTHER | 1 | Mar 29, 2010 | clinicaltrials |
| NCT00054899 | An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer | completed | Phase 1 | 18 | EpimmuneINDUSTRY | 1 | Mar 24, 2010 | clinicaltrials |
| NCT00569114 | Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients | completed | Phase 1 | 45 | Tragara Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 17, 2010 | clinicaltrials |
| NCT00884520 | An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037(VM4-037) | completed | Early Phase 1 | 16 | Siemens Molecular ImagingINDUSTRY | 1 | Mar 16, 2010 | clinicaltrials |
| NCT01034748 | A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers | completed | Phase 1 | 6 | PfizerINDUSTRY | 1 | Mar 12, 2010 | clinicaltrials |
| NCT00456716 | Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma | completed | Phase 2 | 5 | Swedish Medical CenterOTHER | 1 | Mar 4, 2010 | clinicaltrials |
| NCT00103831 | Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 2 | Mar 2, 2010 | clinicaltrials |
| NCT00915330 | Rapid On-site Cytopathologic Evaluation in the Diagnosis of Hilar/Mediastinal Adenopathy | completed | N/A | 164 | Maggiore Bellaria Hospital, BolognaOTHER | 1 | Feb 19, 2010 | clinicaltrials |
| NCT00143455 | Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer | completed | Phase 3 | 485 | PfizerINDUSTRY | 13 | Feb 18, 2010 | clinicaltrials |
| NCT00174772 | Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 72 | SanofiINDUSTRY | 8 | Feb 17, 2010 | clinicaltrials |
| NCT00191139 | Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 64 | Eli Lilly and CompanyINDUSTRY | 4 | Feb 17, 2010 | clinicaltrials |
| NCT00402051 | Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 133 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 17, 2010 | clinicaltrials |
| NCT00039507 | Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | — | Fox Chase Cancer CenterOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00062322 | Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer | completed | Phase 1 | — | Fox Chase Cancer CenterOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00128999 | Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 5 | Alberta Health servicesOTHER | 1 | Feb 9, 2010 | clinicaltrials |
| NCT01060137 | Fentanyl Matrix in Lung Cancer Pain | completed | Phase 4 | 268 | Janssen Korea, Ltd., KoreaINDUSTRY | 0 | Feb 5, 2010 | clinicaltrials |
| NCT00061997 | Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers | completed | Phase 1 | — | British Columbia Cancer AgencyOTHER | 1 | Feb 2, 2010 | clinicaltrials |
| NCT00114192 | Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 37 | University of VirginiaOTHER | 1 | Feb 1, 2010 | clinicaltrials |
| NCT00002901 | Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Jul 28, 2010source: clinicaltrials